We are live on ! Find out more
TGAN

Transphorm, Inc. Common Stock

Delisted

TGAN was delisted on the 20th of June, 2024.

39 hedge funds and large institutions have $147M invested in Transphorm, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

280% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 5

9% less funds holding

Funds holding: 4339 (-4)

26% less capital invested

Capital invested by funds: $198M → $147M (-$51M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
39
Holders Change
-4
Holders Change %
-9.3%
% of All Funds
0.62%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
3
Increased
19
Reduced
5
Closed
7
Calls
Puts
Net Calls
Net Calls Change

TGAN Hedge Fund Activity: Q1 2023 in Review

39 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Transphorm, Inc. Common Stock (TGAN) for Q1 2023, worth a combined $147M — down 26% from $198M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of TGAN and 3 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 19 added.

The largest buyer was JP Morgan Chase, adding an estimated $1.06M. The largest seller was Soros Fund Management, cutting an estimated $150K.

  • 39 institutional investors held Transphorm, Inc. Common Stock (TGAN) as of Q1 2023, down from 43 in Q4 2022.
  • Funds reported $147M of Transphorm, Inc. Common Stock stock for Q1 2023, down 26% quarter-over-quarter.
  • 3 funds opened new Transphorm, Inc. Common Stock positions in Q1 2023 and 7 closed out, a net change of -4 holders.
  • The largest Transphorm, Inc. Common Stock buyer in Q1 2023 was JP Morgan Chase, an estimated $1.06M added.
  • The largest Transphorm, Inc. Common Stock seller in Q1 2023 was Soros Fund Management, an estimated $150K sold.

Based on aggregated 13F filings for Q1 2023.